About Activiomics
Activiomics is a company based in London (United Kingdom) founded in 2009 was acquired by hVIVO in March 2014. Activiomics has raised $805 thousand across 1 funding round from investors including hVIVO and IP Group. Activiomics operates in a competitive market with competitors including Metabolon, Somalogic, Cyrus Biotechnology, Maze Therapeutics and Vividion Therapeutics, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Activiomics Limited
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Activiomics
Activiomics has successfully raised a total of $805K through 1 strategic funding round. The most recent funding activity was a Seed round of $805 thousand completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Activiomics
Activiomics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include hVIVO and IP Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and advisory services are offered across multiple sectors.
|
Locked | Locked | Locked | |
|
Provider of cell based assays, field trial, and molecular services for biopharma sector
|
Locked | Locked | Locked |
Investor details for Activiomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Activiomics
Investment portfolio details for Activiomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Activiomics
Detailed financials for Activiomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Activiomics Comparisons
Peer comparison for Activiomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Activiomics
Activiomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Somalogic, Cyrus Biotechnology, Maze Therapeutics and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| Locked | Locked | Locked |
Protein-based assays are developed for life science research.
|
|
| Locked | Locked | Locked |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| Locked | Locked | Locked |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
Detailed competitors of Activiomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Activiomics
Complete news archive for Activiomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Activiomics
Activiomics was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Activiomics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Activiomics is a funded company, having raised a total of $805K across 1 funding round to date.
Activiomics was founded in 2009 in London, United Kingdom, focusing on the biotechnology sector. Phosphoproteomic technologies are utilized by the company for biomarker identification and drug development support. The TIQAS platform is employed to quantify phosphopeptides, with cell tissues broken down via protease into fragments and analyzed through mass spectrometry. Acquisition by Retroscreen (now hVivo) occurred in March 2014 for 4 million GBP.
Activiomics's top competitors include Alector, Somalogic and Maze Therapeutics.